fiercepharmaMarch 11, 2019
Tag: biotechs , Nasdaq , high-tech board , Shanghai Stock Exchange
China’s securities authorities released final rules for the country’s new Nasdaq-style high-tech board, which could compete with Hong Kong, S.A.R., China and New York for listing of China-based tech companies, including biotechs. To be hosted at Shanghai Stock Exchange, the new board could allow prerevenue biotechs to be listed, provided they have valuations of no less than 4 billion Chinese yuan ($600 million) and at least one product cleared for phase 2 studies, according to the registration rule (Chinese, PDF).
Read More:
http://www.sse.com.cn/lawandrules/sserules/tib/review/a/20190302/a9be0ddb9baed2b57e35f436b4b752d4.pdf
Register as Visitor to CPhI China 2019!
-----------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: